Envista Holdings Corp.
- NVST ยท NYSE
- Dental Equipment & Supplies
- Brea, CA
- 12,000 employees
- CIK 0001757073
Updated from SEC filings through
Top things to know
Executives
-
Paul Keel CEO 8-K, 2026-11-04 - Paul A. Keel Chairman and CEO 4, 2026-08-20
-
Eric D. Hammes Chief Financial Officer 4, 2026-08-27 - Eric Hammes Chief Financial Officer 8-K, 2026-08-19
-
Robert Befidi President, Diagnostics 4, 2026-08-27 -
Stefan Nilsson President, Nobel Biocare 4, 2026-08-27
What leadership is saying
“Envista delivered another quarter of profitable growth, gaining share and expanding margins”
Earnings press release (8-K Ex. 99.1), filed November 4, 2026
Envista Holdings Corp is a U.S. public company in dental equipment & supplies (SIC 3843), headquartered in Brea, CA. It trades as NVST on NYSE. Revenue was $2.7B in the fiscal year ending December 31, 2025, +8.3% from the year before. It reported about 12,000 employees. Paul Keel is CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.7B 10-K, 2026-02-12 | $2.5B 10-K, 2026-02-12 | $2.6B 10-K, 2024-02-15 | $2.6B 10-K, 2024-02-15 | $2.5B 10-K, 2024-02-15 |
| Operating income | $216M 10-K, 2026-02-12 | -$1.0B 10-K, 2026-02-12 | $31.5M 10-K, 2026-02-12 | $319M 10-K, 2025-02-13 | $306M 10-K, 2024-02-15 |
| SG&A | $1.2B 10-K, 2026-02-12 | $1.2B 10-K, 2026-02-12 | $1.1B 10-K, 2026-02-12 | $1.1B 10-K, 2025-02-13 | $1.0B 10-K, 2024-02-15 |
| Net income | $47.0M 10-K, 2026-02-12 | -$1.1B 10-K, 2026-02-12 | -$100M 10-K, 2026-02-12 | $243M 10-K, 2025-02-13 | $341M 10-K, 2024-02-15 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Paul Keel CEO and Chairman at Envista | CEO | 8-K, 2026-11-04 |
| Paul A. Keel | Chairman and CEO | 4, 2026-08-20 |
| Eric D. Hammes | Chief Financial Officer | 4, 2026-08-27 |
| Eric Hammes | Chief Financial Officer | 8-K, 2026-08-19 |
| Robert Befidi President, Diagnostics and Corporate Officer at Envista Holdings Corporation (NYSE: NVST) | President, Diagnostics | 4, 2026-08-27 |
| Stefan Nilsson | President, Nobel Biocare | 4, 2026-08-27 |
 Veronica Acurio | President, Orthodontics | 4, 2026-08-27 |
| Coree Thomas Global accounting leader creating an inclusive environment for high performing finance professionals to thrive! | Vice President and Chief Accounting Officer | 8-K, 2026-06-03 |
 Mischa M. Reis Senior Vice President, Strategy & Corporate Development at Envista Holdings Corporation | Named in proxy bio: Senior Vice President, Strategy and Corporate Development | DEF 14A, 2026-04-07 |
| Faez C. Kaabi | Chief Accounting Officer | 4, 2026-02-27 |
| Mischa Reis | SVP, Strategy & Bus. Dev. | 4, 2026-08-24 |
| Coree K. Thomas | CAO | 3, 2026-08-13 |
 Mark E. Nance SVP & General Counsel, Envista | General Counsel | 4, 2026-02-27 |
What Envista Holdings Corp does
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 160.3 million (as of October 30, 2026) | 10-Q, November 4, 2026 |
|---|---|---|
| Public float | $2.5B (as of June 27, 2025) | 10-K, February 12, 2026 |
| Reportable segments | 2 (period ending October 2, 2026) | 10-Q, November 4, 2026 |
| Latest proxy statement | Meeting December 31, 2025 (filed April 7, 2026) | DEF 14A, April 7, 2026 |
| Auditor | Ernst & Young LLP (Irvine, California) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| August 20, 2026 | Mischa Reis SVP, Strategy & Bus. Dev. | Sale | 8,000 | $220K | Form 4, August 24, 2026 |
| February 10, 2026 | Mischa Reis SVP, Strategy & Bus. Dev. | Sale | 9,675 | $290K | Form 4, February 11, 2026 |
| August 25, 2025 | Mischa Reis SVP, Strategy & Bus. Dev. | Sale | 15,000 | $324K | Form 4, August 27, 2025 |
Recent 8-K events
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-27
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-09-17
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-19
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 8.01 Other events
- 8-K filed 2026-08-05
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-03
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-21
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-06
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-02-05
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2025-10-29
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
Frequently asked questions about Envista Holdings Corp
- What does Envista Holdings Corp do?
- In its own words, from Item 1 of its 10-K: "Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile."
- What is Envista Holdings Corp's revenue?
- $2.7B for the fiscal year ending December 31, 2025, from its 10-K filed February 12, 2026.
- Is Envista Holdings Corp profitable?
- Envista Holdings Corp reported net income of $47.0M for the fiscal year ending December 31, 2025.
- How many employees does Envista Holdings Corp have?
- About 12,000 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Envista Holdings Corp?
- Paul Keel, CEO, as named in a 8-K filed November 4, 2026.
- Who is the CFO of Envista Holdings Corp?
- Eric D. Hammes, Chief Financial Officer, as named in a 4 filed August 27, 2026.
- Where is Envista Holdings Corp headquartered?
- Brea, CA.
- What is Envista Holdings Corp's stock ticker?
- NVST on NYSE.
- What industry is Envista Holdings Corp in?
- Dental Equipment & Supplies, SIC code 3843.
- What is Envista Holdings Corp's website?
- envistaco.com.
- When does Envista Holdings Corp report earnings next?
- February 3, 2027. Source: estimate_8k_pattern.
- Is Envista Holdings Corp a public company?
- Yes. Envista Holdings Corp files with the SEC under CIK 0001757073 and trades as NVST.
- Who audits Envista Holdings Corp?
- Ernst & Young LLP, Irvine, California, as named in its latest annual report (10-K).
- How many shares of Envista Holdings Corp are outstanding?
- 160.3 million shares as of October 30, 2026, from its 10-Q filed November 4, 2026.
- What is Envista Holdings Corp's public float?
- $2.5B as of June 27, 2025, as reported on the cover of its 10-K filed February 12, 2026.
- How many business segments does Envista Holdings Corp report?
- 2 reportable segments for the period ending October 2, 2026, from its 10-Q filed November 4, 2026.
- When is Envista Holdings Corp's annual shareholder meeting?
- December 31, 2025, per its proxy statement (DEF 14A) filed April 7, 2026.
- Have Envista Holdings Corp insiders traded stock recently?
- Since August 25, 2025, officers and directors reported 3 open-market sales worth about $834K and 0 purchases on Forms 4 and 5. The most recent: Mischa Reis (SVP, Strategy & Bus. Dev.) sold 8,000 shares on August 20, 2026.